Interestingly, SMAD7 is overexpressed in the inflamed mucosa of IBD patients (117) and targeting of SMAD7 has shown efficacy in mouse models of colitis (119), while ITGB1 single nucleotide polymorphisms have been identified as a risk factor in IBD (120). Here, SMAD7 is linked to colitis.